Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the...

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Complement component deficiencies (CDs) increase susceptibility to Neisseria meningitidis infections.
• Meningococcal vaccination is recommended for individuals with CDs in the United States.
• Current vaccination rates among this vulnerable population are not well-documented.

Purpose of the Study:

• To assess the uptake of meningococcal vaccines (MenACWY and MenB) in patients diagnosed with complement component deficiencies (CDs) in the United States.
• To identify potential gaps in meningococcal vaccination coverage within this high-risk group.

Main Methods:

• Retrospective analysis of a healthcare database.
• Identification of patients with a diagnosis of complement component deficiencies.
• Evaluation of vaccination records for MenACWY and MenB vaccines within three years of CD diagnosis.

Main Results:

• Only 4.6% of patients with CDs received MenACWY vaccination within three years of diagnosis.
• A mere 2.2% of patients with CDs received MenB vaccination within three years of diagnosis.
• These findings indicate significantly low meningococcal vaccination rates in patients with CDs.

Conclusions:

• Meningococcal vaccination rates among patients with complement component deficiencies are unacceptably low.
• There is a critical need to improve meningococcal vaccination strategies and adherence in this patient population.
• Enhanced efforts are required to ensure adequate protection against meningococcal disease in individuals with CDs.